DMC Biotechnologies

About

DMC Biotechnologies produces bio-based chemicals using fermentation.

1 - 10

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $39M
Industries: Biotechnology,Chemical,Commercial,Food and Beverage,Manufacturing
Founded date: Jan 1, 2014
Number Of Employee: 1 - 10
Operating Status: Active

DMC Biotechnologies produces bio-based chemicals using fermentation. The company's technology makes products using lower energy and resources, with applications that contribute to a sustainable economy. DMC Biotechnologies, Inc. was founded in 2014 by Matt Lipscomb and Mike Lynch and is based in Boulder, Colorado, United States.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$51.88M

DMC Biotechnologies has raised a total of $51.88M in funding over 2 rounds. Their latest funding was raised on Dec 2, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 2, 2021	Series B	$39M	1	—	—	Detail
Dec 18, 2019	Series A	$11.30M	1	—	—	Detail
Aug 30, 2017	Grant	$1.33M	1	National Science Foundation	—	Detail
Dec 18, 2015	Grant	$241.25K	1	National Science Foundation	—	Detail

Investments

Number of Investments

Number of Lead Investments

4

1

DMC Biotechnologies has made 4 investments. Their most recent investment was on Apr 28, 2020, when Aesthetic raised $3.10M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 28, 2020 Aesthetic	Seed	$3.10M	Blockchain	—
May 1, 2019 Golden	Seed	$5M	Artificial Intelligence	—
Jan 1, 2019 Nearside	Seed	$5M	Financial Services	—
Aug 19, 2014 ClearTax	Pre-seed	—	Accounting	Yes